Global Corneal Implant Market is Expected to Showcase a Significant Growth at a CAGR of ~6% by 2030 | DelveInsight
The surge in demand for corneal implants stems mainly from the rise in instances of corneal blindness, eye injuries, and conditions like ocular hypertension (glaucoma). Moreover, the growing collaboration among industry stakeholders to innovate in corneal implant technology, alongside the limited availability of cornea donors, is anticipated to drive the expansion of the corneal implant market from 2024 to 2030.
LAS VEGAS, April 23, 2024 /PRNewswire/ -- DelveInsight's
Corneal Implant Market Insights report provides the current and forecast market analysis, individual leading corneal implant companies' market shares, challenges, corneal implant market drivers, barriers, trends, and key market corneal implant companies in the market.
Key Takeaways from the Corneal Implant Market Report
As per DelveInsight estimates, North America is anticipated to dominate the global corneal implant market during the forecast period.
Notable corneal implant companies such as
EyeYon, AJL Ophthalmic S.A., KeraMed, Inc., Aurolab, CorneaGen, Presbia PLC, LinkoCare Life Sciences AB, MEDIPHACOS, Cornea Biosciences, Advancing Sight Network, Corneat Vision, DIOPTEX, and several others, are currently operating in the corneal implant market.
In
In
July 2019, CorneaGen received USD 37 million in funding for the advanced development of Cornea Cell Therapy.
To read more about the latest highlights related to the corneal implant market, get a snapshot of the key highlights entailed in the
Global Corneal Implant Market Report
Corneal Implant Overview
Corneal implants, also known as corneal inlays, are innovative devices designed to correct refractive errors such as presbyopia, a condition where the eye's ability to focus on nearby objects diminishes with age. These tiny implants are placed within the cornea, the transparent front part of the eye, to enhance its optical properties and improve vision. Unlike traditional eyeglasses or contact lenses, corneal implants offer a more permanent solution with minimal maintenance, providing individuals with clear vision and freedom from dependency on corrective eyewear.
The procedure for inserting corneal implants is relatively quick and minimally invasive, often performed on an outpatient basis. By carefully reshaping the cornea's curvature, these implants can restore near vision, allowing individuals to read, work on computers, and perform other close-up tasks without difficulty. With advancements in technology and materials, corneal implants continue to evolve, offering promising outcomes for those seeking long-term vision correction without the inconvenience of glasses or contacts.
Corneal Implant Market Insights
In 2023, North America dominated the corneal implant market, primarily due to the presence of key industry players in the region. Favorable reimbursement policies, heightened research and development efforts focused on corneal implants, and the escalating burden of corneal blindness all contribute to this growth trend.
Data from the Centers for Disease Control and Prevention (CDC) in 2022 revealed that around 6 million Americans experienced vision loss and 1 million suffered from blindness in 2017. The prevalence of risk factors like diabetes and hypertension, as highlighted in the CDC's National Diabetes Statistics Report of 2020, further exacerbates ocular disorders. With approximately 34.2 million Americans diagnosed with diabetes in 2020 and another 88 million displaying pre-diabetic conditions, the demand for corneal implants is expected to rise as ophthalmic disorders become more prevalent.
Additionally, North America benefits from significant product development and partnership initiatives within the corneal implants sector. Notably, in July 2022, Carl Zeiss Meditec and Precise Bio announced a collaboration aimed at developing and commercializing tissue-based implants, underscoring the region's dynamic corneal implant market landscape.
To know more about why North America is leading the market growth in the corneal implant market, get a snapshot of the
Corneal Implant Market Outlook
Corneal Implant Market Dynamics
The corneal implant market has been witnessing dynamic shifts driven by
technological advancements, the rising prevalence of eye disorders, and
increasing awareness about treatment options. Technological innovations such as advanced materials, improved surgical techniques, and customizable implants are revolutionizing the landscape, offering patients more effective and tailored solutions. Additionally, the
growing aging population and
lifestyle changes leading to conditions like myopia and astigmatism are fueling demand for corneal implants globally.
Moreover,
strategic collaborations between healthcare institutions, research organizations, and industry players further propel market growth. These partnerships facilitate the
development of novel products, streamline regulatory processes, and expand corneal implant market reach. Furthermore, the
adoption of minimally invasive procedures and
outpatient surgeries is driving market expansion by reducing patient recovery time, lowering healthcare costs, and enhancing overall patient satisfaction.
However, challenges such as
stringent regulatory requirements, limited reimbursement policies, and the high cost of advanced implants pose barriers to corneal implant market growth. Overcoming these hurdles requires concerted efforts from stakeholders to streamline regulatory frameworks, increase insurance coverage, and invest in research and development to bring down costs. Despite these challenges, the corneal implant market is poised for steady growth as technological innovations continue to improve treatment outcomes and expand the scope of therapeutic options for patients with corneal disorders.
Get a sneak peek at the corneal implant market dynamics @
Corneal Implant Market Dynamics Analysis
Corneal Implant Market Assessment
Corneal Implant Market Segmentation
Corneal Implant Market Segmentation By Procedure: Endothelial Keratoplasty, Penetrating Keratoplasty, and Others
Corneal Implant Market Segmentation By Disease: Keratoconus, Fuchs Dystrophy, Infectious Keratitis, Corneal Ulcers, and Others
Corneal Implant Market Segmentation By End User: Hospitals, Eye Clinics, and Ambulatory Surgical Centers
Corneal Implant Market Segmentation By Geography: North America, Europe, Asia-Pacific, and Rest of World
Porter's Five Forces Analysis, Product Profiles,
Case Studies, KOL's Views, Analyst's View
Which MedTech key players in the corneal implant market are set to emerge as the trendsetter explore @
Corneal Implant Companies
Table of Contents
Interested in knowing the corneal implant market by 2030? Click to get a snapshot of the
Corneal Implant Market Trends
Related Reports
Fuchs Endothelial Corneal Dystrophy Market Insight, Epidemiology, and Market Forecast – 2034 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key FECD companies, including
Kowa Pharmaceuticals, Trefoil Therapeutics, ProQR Therapeutics, and Emmecell, among others.
Keratoconus Market
Keratoconus
Market Insight, Epidemiology, and Market Forecast – 2032 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key keratoconus companies, including
Glaukos, Avedro, Glaukos Corporation, Sooft Italia, Lightmed OptiMed, Peschke Meditrade GmbH, iVeena Delivery Systems, among others.
Keratitis Market
Merck & Co, Bausch Health, Gilead Biosciences, Pfizer, and Glenmark Pharmaceuticals, among others.
Corneal Ulcer Market
Corneal Ulcer Market Insight, Epidemiology, and Market Forecast – 2032 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key corneal ulcer companies, including
DompéFarmaceutica, Claris Biotherapeutics, ReGenTree, LLCR, among others.
About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports pharma companies by providing comprehensive end-to-end solutions to improve their performance.
Contact Us
Shruti Thakur
[email protected]
+14699457679
https://www.delveinsight.com/medical-devices
Logo: https://mma.prnewswire.com/media/1082265/DelveInsight_Logo.jpg
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
Targets
-Drugs
Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.